Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Other Non-Current Liabilities (2016 - 2022)

vTv Therapeutics' Other Non-Current Liabilities history spans 9 years, with the latest figure at $770000.0 for Q1 2022.

  • For Q1 2022, Other Non-Current Liabilities rose 1440.0% year-over-year to $770000.0; the TTM value through Mar 2022 reached $770000.0, up 1440.0%, while the annual FY2021 figure was $1.3 million, 2424.0% up from the prior year.
  • Other Non-Current Liabilities for Q1 2022 was $770000.0 at vTv Therapeutics, down from $1.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.3 million in Q4 2021 and bottomed at $50000.0 in Q4 2020.
  • The 5-year median for Other Non-Current Liabilities is $258000.0 (2018), against an average of $276294.1.
  • The largest annual shift saw Other Non-Current Liabilities crashed 80.77% in 2020 before it surged 2424.0% in 2021.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $260000.0 in 2018, then changed by 0.0% to $260000.0 in 2019, then plummeted by 80.77% to $50000.0 in 2020, then soared by 2424.0% to $1.3 million in 2021, then crashed by 38.99% to $770000.0 in 2022.
  • Per Business Quant, the three most recent readings for VTVT's Other Non-Current Liabilities are $770000.0 (Q1 2022), $1.3 million (Q4 2021), and $50000.0 (Q3 2021).